Lv1
78 积分 2023-09-12 加入
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
1个月前
已完结
From TCR fundamental research to innovative chimeric antigen receptor design
5个月前
已完结
A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of the LVIVO-TaVec100 Product in the Treatment of Relapsed/Refractory B-cell Malignancies
7个月前
已关闭
IL-10-expressing, anti-CD19 CAR T cells for patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: an open-label, single-arm, phase 1 study
7个月前
已关闭
IL-10-expressing, anti-CD19 CAR T cells for patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: an open-label, single-arm, phase 1 study
7个月前
已完结
Noncanonical and mortality-defining toxicities of CAR T cell therapy
9个月前
已完结
Mechanisms of Endocytosis
10个月前
已完结
皖公网安备34019202002308
